Comisión Nacional de Investigación Científica y Tecnológica   Report issue

Government Phase 1 Phase 2
Founded: Santiago Chile (1967)

Organization Overview

First Clinical Trial
2017
NCT03213405
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Comisión Nacional de Investigación Científica y Tecnológica

Active Ingredients

Drugs in Phase 2 Trials (1)

acetylcysteine (mucomyst) (1 trial)

Drugs in Phase 1 Trials (2)

bacille calmette-guerin (1 trial)

rbcg-n-hrsv (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cocaine-Related Disorders (Phase 2)

Respiratory Syncytial Virus Infections (Phase 1)

Virus Diseases (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 3